drugset / Trial / NCT05915013

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response

NCT05915013

RandomizedCrossoverDouble-blindBasic science

Summary

The proposed study will assess the combined effect of perampanel and ketamine on the anti-depressant response in individuals with treatment resistant depression. The purpose of this study is to test the hypothesis that stimulation of Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid receptors (AMPAR) is critical to the anti-depressant response of ketamine.

Timeline

Start
2023-09-07
Primary completion
2032-12
Completion
2032-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule Intravenous
Subject Perampanel Small molecule 6 mg Oral